Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2017

View Archived Issues

Proteostasis Therapeutics files IND with FDA for CFTR potentiator

BMS-986016 in combination with nivolumab shows promise for the treatment of melanoma

[68Ga]NOTA-RM-26 detects breast cancer in pilot study

FDA approves Gleolan intraoperative imaging agent for malignant glioma

First-in-human trial data reported for antibody-drug conjugate IMGN-779

Phase I results for LY-3022855 in patients with advanced solid tumors

Genentech presents phase Ib data for GDC-0919 and atezolizumab in advanced solid tumors

FDA awards fast track designation to Synlogic's SYNB-1020

European Commission approves Kevzara for rheumatoid arthritis

Rhythm and Camurus report initial phase Ia results on extended-release setmelanotide

STK-01 set to move into phase I trial for bladder cancer under new agreement

Danazol shows promise for treating MDS-associated thrombocytopenia

Skin-derived neural precursor cells improve canine model of Alzheimer's disease

Heinrich-Heine-Universitaet Duesseldorf patents NMDA receptor antagonists

Centro de Investigacion Biomedica en Red and collaborators divulge AMPK activators

FDA awards orphan drug designation to Propanc's PRP for pancreatic cancer

Wockhardt presents compounds for treating bacterial infections

Teijin Pharma discovers androgen receptor agonists

Horizon completes sale of Procysbi and Quinsair rights in EMEA

Clarus resubmits NDA for Jatenzo

Merck & Co. discloses leukotriene BLT1 receptor antagonists

Bluebird reports interim data from Starbeam study of Lenti-D in cerebral adrenoleukodystrophy

pSivida submits MAA in E.U. for Durasert 3-year treatment for posterior segment uveitis

Stivarga for HCC approved in Japan, recommended for approval in E.U.

OSE pauses new patient recruitment in phase III NSCLC study of Tedopi

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...